Master the essentials of key pricing and rebate concepts and methodologies, including IRA reforms and Proposed Revisions to the MDRP.

Welcome to American Conference Institute’s (ACI’s) Passport to Proficiency on Rx Drug Pricing and Rebate Fundamentals. We have designed this course to make you proficient in essential pricing and rebate concepts under Medicaid, Medicare, and other related government payor programs, including those under the auspices of PHS 340B, the VA, and DoD.

We have refreshed our course agenda to include in-depth sessions on changes to the pricing and rebate system under the Inflation Reduction Act as well as proposed changes to the Medicaid Drug Rebate Program under CMS’s newly Proposed Rule: Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program.

This intensive training program will give novices and experienced practitioners alike a thorough understanding of core pricing competencies and applicable changes in the reimbursement structures of key payor programs.

Gain exclusive and unparalleled access to an in-depth guide on navigating the legal and regulatory maze of prescription drug pricing and rebates. ACI’s goal is to provide you with a live glossary of essential pricing terminology, as well as analysis of the latest developments affecting Rx drug pricing and rebates including the CMS final rule on MDRP, actions on 340b pricing and co-pays and more…

We will provide a complete course of study for foundational elements, as well as a strategy guide for tackling complex challenges that will benefit the industry novice and the veteran.

Let us help you master the fundamentals and prepare for the complexities.

2024 Session Calendar

Week 1
November 4 & November 6

Drug Pricing and Rebate Essentials and Introduction to Medicaid

Week 2
November 12 & November 13

PHS 340B

VA and DOD Rx Pricing and Rebates

*this week will be on Tuesday and Wednesday to observe Veterans Day

Week 3
November 18 & November 20

Medicare Pricing and Rebate Essentials

Advanced CMS Pricing and Rebate Topics

Week 4
December 2 & Decemeber 4

Pricing and Reimbursement for New Products and Therapies


UNDERSTAND how price is established and how the rebate system works

DEFINE key pricing terms under Medicaid, Medicare, PHS 340 and other key government payor programs

MAKE sense of complex pricing and rebate calculations that go beyond the essentials

EXAMINE the latest developments impacting government drug pricing and rebate programs, from reforms instituted under the IRA to CMS’s newly Proposed Rule which would significantly amend the MDRP

COMPREHEND pricing strategies and key considerations for new products and therapies

  • Attorneys with practice areas in:
    • Government Contracts and Managed Markets
    • Pharmaceuticals
    • Healthcare
    • Food & Drug
  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
    • Pricing
    • Business Development
  • Financial Analysts
  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
    • Pricing, Pricing Strategy, Pricing Analytics
    • Contracts and Reimbursement
    • Managed Markets
    • Managed Care
    • Government Programs
    • Medicaid/Medicare Rebates
    • Finance/Accounting/Audit
    • Government Affairs
  • Compliance Officers
  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
    • Contract Management
    • Network Pharmacy
    • Retail Pharmacy Operations
    • Government Programs
    • Pricing and Operations
    • Clinical Operations
    • Industry Relations
  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
    • Pharmacy Networks
    • Pharmaceutical Contracting
    • Clinical
    • Pharmacy Services
Quote Icon

Excellent and very capable list of speakers. Not always this good and comprehensive at other programs.

VP, Us Commercial Legal Lundbeck LLC
Quote Icon

All encompassing overview of government program and current issues.

Director of Pricing and Contracts, Horizon Pharmaceuticals
Related Conference

American Conference Institute is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of Continuing Professional Education (CPE) on the National Registry of CPE Sponsors.

Boards of Accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website:

For more information, visit our webpage.